acetazolamide
Generic: acetazolamide
Labeler: avpakDrug Facts
Product Profile
Brand Name
acetazolamide
Generic Name
acetazolamide
Labeler
avpak
Dosage Form
TABLET
Routes
Active Ingredients
acetazolamide 250 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50268-054
Product ID
50268-054_47e22404-7bca-908d-e063-6294a90a70c1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209734
Listing Expiration
2027-12-31
Marketing Start
2020-07-07
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50268054
Hyphenated Format
50268-054
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acetazolamide (source: ndc)
Generic Name
acetazolamide (source: ndc)
Application Number
ANDA209734 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
Packaging
- 50 BLISTER PACK in 1 BOX (50268-054-15) / 1 TABLET in 1 BLISTER PACK (50268-054-11)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47e22404-7bca-908d-e063-6294a90a70c1", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "unii": ["O3FX965V0I"], "rxcui": ["197304"], "spl_set_id": ["a9dca448-5511-413e-e053-2a95a90a8c66"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 BOX (50268-054-15) / 1 TABLET in 1 BLISTER PACK (50268-054-11)", "package_ndc": "50268-054-15", "marketing_start_date": "20200707"}], "brand_name": "Acetazolamide", "product_id": "50268-054_47e22404-7bca-908d-e063-6294a90a70c1", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "50268-054", "generic_name": "Acetazolamide", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "250 mg/1"}], "application_number": "ANDA209734", "marketing_category": "ANDA", "marketing_start_date": "20200707", "listing_expiration_date": "20271231"}